Scandinavian journal of gastroenterology
-
Scand. J. Gastroenterol. · Nov 1994
Comparative StudyEffects of dobutamine on hepatosplanchnic hemodynamics in patients with chronic liver disease.
It is said that catecholamines increase hepatic blood flow in patients without liver diseases, although several reports have suggested a blunted response to catecholamines in patients with liver cirrhosis. ⋯ These results indicate that dobutamine has less effect on hepatic circulation in patients with liver cirrhosis than in those without liver diseases, indicating that the value of dobutamine in increasing hepatic blood flow in cirrhotic patients is very limited.